Pipeline of DLL3-Targeted Immunotherapy
DLL3: competitors of clinically validated target develop effector-enhanced next generation product candidates STUTTGART, Germany I August 05, 2025 I La…
Pipeline of TSLP Inhibitors and TSLP Receptor Antagonists
TSLP (thymic stromal lymphoprotein) is a clinically and commercially validated inflammatory target attracting numerous competitors STUTTGART, Germany I August 05,…
Pipeline of TL1A Inhibitors & DR3 Antagonists
TL1A (TNF-like ligand 1A): the next big, clinically validated target for inflammatory bowel disease STUTTGART, Germany I August 05, 2025…
Pipeline of Folate Receptor alpha (FRα) Targeted Therapy
Folate Receptor alpha: a clinically validated target for ovarian cancer with commercial potential and a decent competitive environment STUTTGART, Germany…
Pipeline of Fibroblast Activation Protein (FAP) Targeted Therapy
Fibroblast Activation Protein: an emerging high-value theranostic target for delivery of payloads STUTTGART, Germany I August 05, 2025 I La…
Pipeline of Glypican-3 (GPC3) Targeted Therapy
Glypican-3 (GPC3): an emerging liver cancer target with opportunities for different effector mechanisms STUTTGART, Germany I August 05, 2025 I…
Pipeline of B7-H3-Targeted Immunotherapy
B7-H3: an emerging solid tumor target with promise for antibody-drug conjugates STUTTGART, Germany I August 05, 2025 I La Merie…
In vivo expression of antibodies by DNA or RNA: an emerging new drug modality to overcome limitations of passive immunotherapy
STUTTGART, Germany I June 28, 2025 I Vectorized antibodies obtained by in vivo expression of DNA or RNA are an…
Innovation fuels the biologics market growth of therapeutic antibodies and proteins in 2024
The report covers 2024 sales data of innovator therapeutic antibodies and proteins, biosimilars and the novel biologic drug modalities gene…
Outstanding antitumor activity of first-in-class and so far best-in-class PD-1xVEGF bispecific antibody opens up plenty of opportunities for business deals and better followers
STUTTGART, Germany I February 19, 2025 I La Merie Publishing released its newest report with a landscape description and analysis…